Redburn Gene Therapy Virtual Summit 2021

The 2021 Redburn Gene Therapy Summit, Part 2

CGT Catapult invited to send a speaker for Bioprocessing session: 15 min presentation followed by roundtable discussion

Jonathan Appleby, Chief Scientific Officer

Session 2: Can Bioprocessing Step Up? 

  • Manufacturing the viral vectors used in gene therapy is an expensive, inefficient process which needs to improve


  • Jonathan Appleby, Chief Scientific Officer
  • Peter Guterstam, Product Management, Cytiva

View the full agenda and register here

  • Find your perfect job in the Cell and Gene Therapy sector 🤩 We have a whole range of exciting new vacancies over o… 1 day 3 hours ago

Discover who we are